| 國立臺灣大學 |
2012 |
Registry of Lipid Control and the Use of Lipid-lowering Drugs for Secondary Prevention of Cardiovascular Events in Patients with Established Atherosclerotic Disease in Taiwan: Rationality and Methods
|
Yin, Wei-Hsian; Wu, Chau-Chung; Chen, Jaw-Wen; 吳造中 |
| 國立臺灣大學 |
2012 |
Registry of Lipid Control and the Use of Lipid-lowering Drugs for Secondary Prevention of Cardiovascular Events in Patients with Established Atherosclerotic Disease in Taiwan: Rationality and Methods
|
Yin, Wei-Hsian; Wu, Chau-Chung; Chen, Jaw-Wen; 吳造中 |
| 臺大學術典藏 |
2020-03-04T09:03:12Z |
Registry of lipid control and the use of lipid-lowering drugs for secondary prevention of cardiovascular events in patients with established atherosclerotic disease in Taiwan: Rationality and methods
|
Yin W.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2018-09-10T04:11:16Z |
Reglochemistry in Electrophilic Reactions of Propanedlthio-Substituted Allylic Anions Influenced by the γ-Substituents
|
JIM-MIN FANG; JIM-MIN FANG; JIM-MIN FANG |
| 國立臺灣大學 |
1992 |
Regloselective Reactions of Monosaccharides and Disaccharides by Enzymes
|
Wu, Shih-Hsiung; Ong, Geok-Toh; Hsiao, Kwo-Feng; Wang, Kung-Tsung |
| 臺大學術典藏 |
2022-08-19T00:20:30Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
Ou D.-L.; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; Cheng A.-L.; Yang M.-H.; CHIUN HSU |
| 臺大學術典藏 |
2021-04-21T23:30:44Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
DA-LIANG OU; Chen, Chia Wei; Chia-Lang Hsu; Chung, Chih Hung; Feng, Zi Rui; Lee, Bin Shyun; ANN-LII CHENG; Yang, Muh Hwa; CHIUN HSU |
| 臺大學術典藏 |
2021-09-15T01:20:46Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
Ou D.-L.; Chen C.-W.; CHIA-LANG HSU; Chung C.-H.; Feng Z.-R.; Lee B.-S.; Cheng A.-L.; Yang M.-H.; Hsu C. |
| 臺大學術典藏 |
2022-02-08T06:27:20Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
DA-LIANG OU; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; Cheng A.-L.; Yang M.-H.; Hsu C. |
| 臺大學術典藏 |
2022-02-21T02:04:36Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
Ou D.-L.; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; ANN-LII CHENG; Yang M.-H.; Hsu C. |
| 臺大學術典藏 |
2021-08-31T06:29:40Z |
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Bruix J.; Qin S.; Merle P.; Granito A.; Huang Y.-H.; Bodoky G.; Pracht M.; Yokosuka O.; Rosmorduc O.; Breder V.; Gerolami R.; Masi G.; Ross P.J.; Song T.; Bronowicki J.-P.; Ollivier-Hourmand I.; Kudo M.; ANN-LII CHENG; Llovet J.M.; Finn R.S.; LeBerre M.-A.; Baumhauer A.; Meinhardt G.; Han G. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial
|
Xu J.; Xu R.-H.; Qin S.; Pan H.; Bai Y.; Chi Y.; Wang L.; Bi F.; Cheng Y.; Liu T.; Ma D.; Shen L.; Ba Y.; Liang J.; Wang X.; Yau T.C.C.; Ma B.B.; KUN-HUEI YEH; Lin J.-K.; Kappeler C.; Shapiro J.; Kalmus J.; Li J. |
| 臺大學術典藏 |
2018-09-10T15:17:40Z |
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Li, J. and Qin, S. and Xu, R. and Yau, T.C.C. and Ma, B. and Pan, H. and Xu, J. and Bai, Y. and Chi, Y. and Wang, L. and Yeh, K.-H. and Bi, F. and Cheng, Y. and Le, A.T. and Lin, J.-K. and Liu, T. and Ma, D. and Kappeler, C. and Kalmus, J. and Kim, T.W.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Li J.; Qin S.; Xu R.; Yau T.C.C.; Ma B.; Pan H.; Xu J.; Bai Y.; Chi Y.; Wang L.; KUN-HUEI YEH; Bi F.; Cheng Y.; Le A.T.; Lin J.-K.; Liu T.; Ma D.; Kappeler C.; Kalmus J.; Kim T.W. |
| 國家衛生研究院 |
2022-03-10 |
Regorafenib reverses temozolomide-induced CXCL12/CXCR4 signaling and triggers apoptosis mechanism in glioblastoma
|
Chiang, IT;Liu, YC;Liu, HS;Ali, AAA;Chou, SY;Hsu, TI;Hsu, FT |
| 國立交通大學 |
2014-12-08T15:36:08Z |
RegPhos 2.0: an updated resource to explore protein kinase-substrate phosphorylation networks in mammals
|
Huang, Kai-Yao; Wu, Hsin-Yi; Chen, Yi-Ju; Lu, Cheng-Tsung; Su, Min-Gang; Hsieh, Yun-Chung; Tsai, Chih-Ming; Lin, Kuo-I; Huang, Hsien-Da; Lee, Tzong-Yi; Chen, Yu-Ju |
| 元智大學 |
2014-4-1 |
RegPhos 2.0: an updated resource to explore protein kinase-substrate phosphorylation networks in mammals
|
Kai-Yao Huang; Hsin-Yi Wu; Yi-Ju Chen; Cheng-Tsung Lu; Min-Gang Su; Yun-Chung Hsieh; Chih-Ming Tsai; Kuo-I Lin; Hsien-Da Huang; Tzong-Yi Lee; Yu-Ju Chen |
| 元智大學 |
2014-4-1 |
RegPhos 2.0: an updated resource to explore protein kinase-substrate phosphorylation networks in mammals
|
Kai-Yao Huang; Hsin-Yi Wu; Yi-Ju Chen; Cheng-Tsung Lu; Min-Gang Su; Yun-Chung Hsieh; Chih-Ming Tsai; Kuo-I Lin; Hsien-Da Huang; Tzong-Yi Lee; Yu-Ju Chen |
| 元智大學 |
2014-4-1 |
RegPhos 2.0: an updated resource to explore protein kinase-substrate phosphorylation networks in mammals
|
Kai-Yao Huang; Hsin-Yi Wu; Yi-Ju Chen; Cheng-Tsung Lu; Min-Gang Su; Yun-Chung Hsieh; Chih-Ming Tsai; Kuo-I Lin; Hsien-Da Huang; Tzong-Yi Lee; Yu-Ju Chen |
| 國立交通大學 |
2014-12-08T15:37:55Z |
RegPhos: a system to explore the protein kinase-substrate phosphorylation network in humans
|
Lee, Tzong-Yi; Hsu, Justin Bo-Kai; Chang, Wen-Chi; Huang, Hsien-Da |
| 元智大學 |
2011-01 |
RegPhos: a system to explore the protein kinase-substrate phosphorylation network in humans
|
Tzong-Yi Lee; Justin Bo-Kai Hsu; Wen-Chi Chang; Hsien-Da Huang |
| 國立成功大學 |
2011-01 |
RegPhos: a system to explore the protein kinase-substrate phosphorylation network in humans
|
Lee, Tzong-Yi; Hsu, Justin Bo-Kai; Chang, Wen-Chi; Huang, Hsien-Da |
| 國立交通大學 |
2014-12-08T15:12:44Z |
Regression analysis based on semicompeting risks data
|
Hsieh, Jin-Jian; Wang, Weijing; Ding, A. Adam |
| 國立政治大學 |
2017-01 |
Regression analysis for bivariate gap time with missing first gap time data
|
黃佳慧; Huang, C.-H.; Chen, Y.-H. |
| 國立交通大學 |
2014-12-08T15:09:42Z |
REGRESSION ANALYSIS FOR CUMULATIVE INCIDENCE PROBABILITY UNDER COMPETING RISKS
|
Chang, Wei-Hwa; Wang, Weijing |
